Which Weight Management Injection Suits Your Lifestyle?
Compare Wegovy And Mounjaro: Private vs NHS Routes
When you compare Wegovy and Mounjaro through private prescription services, the most significant advantage becomes access speed rather than medication differences. The NHS route requires GP referral to specialist weight management services, often involving 6+ month waiting lists and strict BMI criteria with documented failed diet attempts. Private prescription eliminates these barriers entirely. Both treatments require the same clinical assessment standards, but EverydayMeds' qualified prescribers can review your suitability within 24 hours rather than months.
The clinical reality when you compare Wegovy and Mounjaro mechanisms reveals important distinctions: Wegovy contains semaglutide (pure GLP-1 receptor agonist), while Mounjaro uses tirzepatide (dual GIP and GLP-1 receptor agonist). Both are prescription-only medicines requiring careful dose escalation under medical supervision. Your prescriber will consider factors like your medical history, current medications, and lifestyle preferences when determining which option may better suit your weight management goals alongside a reduced-calorie diet and increased physical activity.
Wegovy And Mounjaro Pricing: Private Prescription Value
EverydayMeds offers transparent pricing when you compare Wegovy and Mounjaro costs privately. Wegovy starts at £79.99 for the 0.25mg starter dose with discount code FIRST40 applied at checkout, escalating to £209.99 for the 2.4mg maintenance dose. Our bundle options provide convenience rather than savings: the Intro Trio (covering your first 12 weeks with 0.25mg, 0.5mg, and 1mg doses) costs £299.99, ensuring uninterrupted treatment progression. Returning customers benefit from the DOSE25 discount code at checkout.
Mounjaro pricing follows a different structure, though both medications represent similar monthly investment at maintenance doses. When you compare Wegovy and Mounjaro total treatment costs, consider that both require long-term commitment for sustained results. The STEP 1 extension trial demonstrated that patients regained approximately two-thirds of their weight loss within one year of stopping treatment, emphasising that weight management represents an ongoing healthcare investment rather than a short-term intervention.
Clinical Evidence When You Compare Wegovy And Mounjaro
The STEP clinical trial programme provides robust evidence for Wegovy's efficacy when you compare Wegovy and Mounjaro research foundations. In STEP 1, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The SELECT cardiovascular outcomes trial further demonstrated a 20% reduction in major cardiovascular events, highlighting benefits beyond weight management.
Direct head-to-head comparisons between Wegovy and Mounjaro remain limited due to different trial designs and patient populations. Both medications have demonstrated significant efficacy in their respective clinical programmes, but your individual response may vary. The dual-receptor mechanism of Mounjaro theoretically offers different pathways for appetite regulation, though clinical significance varies between patients when you compare Wegovy and Mounjaro real-world outcomes.
How Wegovy Works: GLP-1 Mechanism Explained
Understanding Wegovy's mechanism helps when you compare Wegovy and Mounjaro approaches to weight management. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural incretin hormones. These hormones are released after eating and signal satiety to your brain's appetite control centres. By activating GLP-1 receptors, Wegovy may help reduce appetite and promote feelings of fullness after smaller meals. The medication also slows gastric emptying, potentially reducing food cravings throughout the day. This mechanism works most effectively alongside dietary modifications and increased physical activity, as demonstrated in clinical trials.
Private Prescription Ordering Process
EverydayMeds streamlines the process when you compare Wegovy and Mounjaro access options privately. Our 3-minute online clinical assessment captures essential medical history, current medications, and weight management goals without requiring GP involvement. Qualified prescribers review applications within standard 3 working days, or 24 hours with express service. Once approved, both Wegovy and Mounjaro ship via next-day cold-chain delivery, maintaining the 2-8°C temperature requirements throughout transit. This eliminates the complexity of collecting temperature-sensitive medications from high street pharmacies during working hours. Your prescriber remains available for ongoing support and dose adjustment guidance throughout treatment.
Storage And Practical Considerations
Storage requirements present a key differentiator when you compare Wegovy and Mounjaro practicality. Both medications require refrigeration at 2-8°C before first use, but Wegovy offers superior travel flexibility with 6 weeks stability at room temperature below 30°C once removed from the fridge. Mounjaro maintains stability for only 21 days at room temperature, potentially limiting travel or lifestyle flexibility. Wegovy's FlexTouch pen design provides intuitive dose administration with clear dose escalation from 0.25mg weekly through to 2.4mg maintenance. The structured dose escalation cannot be skipped, as it allows your body to adapt gradually while minimising potential side effects. Both treatments require once-weekly subcutaneous injection, typically in the thigh, abdomen, or upper arm.
Compare Wegovy And Mounjaro: Dual-Receptor Innovation
The pharmaceutical landscape evolved significantly when tirzepatide (Mounjaro) introduced dual-receptor targeting compared to Wegovy's single GLP-1 approach. Mounjaro activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptors, potentially offering enhanced metabolic benefits through multiple pathways. This dual mechanism may provide different appetite regulation patterns, though individual responses vary considerably when you compare Wegovy and Mounjaro patient experiences.
Private prescription access allows you to discuss both options thoroughly with qualified prescribers who understand these mechanistic differences. Unlike NHS protocols that may favour one treatment based on local guidelines or availability, private consultation enables personalised selection. Your prescriber can consider factors like your eating patterns, lifestyle demands, travel requirements, and medical history when you compare Wegovy and Mounjaro suitability for your specific circumstances.
Expert Guidance And Treatment Selection
EverydayMeds' clinical team provides ongoing support when you compare Wegovy and Mounjaro options or require treatment adjustments. Our GPhC-registered pharmacy (#9012878) ensures both medications meet identical quality standards to NHS supplies, sourced directly from licensed manufacturers. Whether you choose Wegovy or Mounjaro, our prescribers monitor your progress and can modify approaches if needed. Both treatments are prescription-only medicines requiring medical supervision, particularly during dose escalation phases. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment, with discount codes FIRST40 for new customers or DOSE25 for returning patients applied at checkout. Both Wegovy and Mounjaro are available from EverydayMeds — your prescriber can help determine which option aligns with your weight management goals and lifestyle requirements.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
